A detailed history of Steadfast Capital Management LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Steadfast Capital Management LP holds 2,313,439 shares of BSX stock, worth $176 Million. This represents 3.84% of its overall portfolio holdings.

Number of Shares
2,313,439
Previous 3,036,039 23.8%
Holding current value
$176 Million
Previous $176 Million 9.72%
% of portfolio
3.84%
Previous 4.4%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $41.6 Million - $49.6 Million
-722,600 Reduced 23.8%
2,313,439 $158 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $15.3 Million - $18.2 Million
314,000 Added 11.54%
3,036,039 $176 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $32 Million - $34.8 Million
637,085 Added 30.56%
2,722,039 $144 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $22.4 Million - $24.6 Million
451,029 Added 27.6%
2,084,954 $113 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $61.8 Million - $68.5 Million
-1,369,511 Reduced 45.6%
1,633,925 $81.7 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $119 Million - $142 Million
3,003,436 New
3,003,436 $139 Million
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $60.3 Million - $80.6 Million
-1,710,408 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $70 Million - $77.1 Million
1,710,408 New
1,710,408 $75.8 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $314 Million - $398 Million
-9,475,750 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $7.45 Million - $9.13 Million
216,188 Added 2.33%
9,475,750 $362 Million
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $158 Million - $205 Million
5,241,282 Added 130.44%
9,259,562 $325 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $104 Million - $184 Million
4,018,280 New
4,018,280 $131 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Steadfast Capital Management LP Portfolio

Follow Steadfast Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steadfast Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Steadfast Capital Management LP with notifications on news.